Wheeler, D L <br/><br/>
Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members.  [electronic resource] 

 -  Oncogene  Jun 2008 
 - 3944-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2008.19  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--chemistry<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cetuximab<br/>Drug Resistance, Neoplasm<br/>Endocytosis<br/>ErbB Receptors--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Models, Biological<br/>Neoplasms--drug therapy<br/>RNA Interference<br/>Receptor, ErbB-2--metabolism<br/>Receptor, ErbB-3--metabolism